首页> 外文期刊>Molecules >Isolation, Characterization and Antiproliferative Activity of New Metabolites from the South African Endemic Red Algal Species Laurencia alfredensis
【24h】

Isolation, Characterization and Antiproliferative Activity of New Metabolites from the South African Endemic Red Algal Species Laurencia alfredensis

机译:南非特有红藻物种Laurencia alfredensis的新代谢产物的分离,表征和抗增殖活性

获取原文
获取外文期刊封面目录资料

摘要

The marine red algae of the genus Laurencia have been widely studied for their structurally diverse and biologically active secondary metabolites. We report here the natural product investigation of the organic extract of a newly identified South African endemic species, Laurencia alfredensis. A sequence of column chromatography, preparative TLC and normal phase HPLC resulted in the isolation of eleven compounds comprising three labdane-type diterpenes (1–3), four polyether triterpenes (4–7), three cholestane-type ecdysteroids (8–10) and a glycolipid (11). Compounds 1–3, 5–8 and 10 have not previously been reported, while compound 9 is reported here for the first time from a natural source and the known compound 11 isolated for the first time from the genus Laurencia. The structural elucidation and the relative configuration assignments of the compounds were accomplished by extensive use of 1D- and 2D-NMR, HR-ESI-MS, UV and IR spectroscopic techniques, while the absolute configuration of compound 1 was determined by single-crystal X-ray diffraction analysis. All compounds were evaluated against the MDA-MB-231 breast and HeLa cervical cancer cell lines. Compound 2 exhibited low micromolar antiproliferative activity (IC50 = 9.3 μM) against the triple negative breast carcinoma and compound 7 was similarly active (IC50 = 8.8 μM) against the cervical cancer cell line. View Full-Text
机译:劳伦西亚(Laurencia)属的海洋红藻因其结构多样且具有生物活性的次生代谢产物而被广泛研究。我们在这里报告了新发现的南非特有物种Laurencia alfredensis的有机提取物的天然产物调查。通过一系列柱色谱,制备型TLC和正相HPLC分离出11种化合物,其中包括三种拉丹烷型二萜(1-3),四种聚醚三萜(4-7),三种胆固醇型蜕皮甾类(8-10)和糖脂(11)。以前没有化合物1-3、5-8和10的报道,而化合物9是首次从天然来源中报道,已知化合物11首次从劳伦西亚属中分离出来。通过广泛使用1D和2D-NMR,HR-ESI-MS,UV和IR光谱技术完成化合物的结构阐明和相对构型分配,而化合物1的绝对构型由单晶X确定射线衍射分析。所有化合物均针对MDA-MB-231乳腺癌和HeLa宫颈癌细胞系进行了评估。化合物2对三阴性乳腺癌表现出低的微摩尔抗增殖活性(IC50 = 9.3μM),化合物7对宫颈癌细胞系具有类似的活性(IC50 = 8.8μM)。查看全文

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号